How retinal screening moves the needle on value-based care

Under value-based contracts, the diabetic eye exam is one of the most stubborn gaps in the book. The measure looks simple — every patient with diabetes needs a retinal exam — but the standard workflow buries it under a referral to an outside eye specialist who may book weeks out and may never close the loop back to your chart. The result is a care gap that drags on quality scores, risk adjustment, and the patient’s vision all at once.

Point-of-care retinal screening flips the equation. When the image is captured during a visit the patient already showed up for, and a board-certified ophthalmologist reads it within 24–48 hours, the gap closes inside your four walls — no referral, no leakage, no waiting.

Which quality measure are we actually talking about?

The headline measure is the HEDIS Eye Exam for Patients with Diabetes (EED), which feeds the diabetes-care composite in Medicare Advantage Star Ratings and many commercial and Medicaid value-based arrangements. A retinal image read by a qualified reader satisfies the measure for that measurement year (and, when documented as negative for retinopathy, can carry forward under current specifications). One screening event can move a metric that otherwise requires a completed outside specialist visit.

Why closing it in-house beats the referral

Referrals fail quietly. The patient doesn’t schedule, the specialist’s note never arrives, or the appointment lands after the measurement year closes. Each of those is a missed numerator hit you may not discover until the gap report lands.

Screening at the point of care removes the failure points:

• No appointment to miss. The exam happens during a visit that’s already on the calendar.
• No documentation chase. The structured report comes back to you, ready to attach to the chart.
• No network leakage. The patient stays your patient; you keep the relationship and the credit.
• No new hire. Your staff captures the image with a fundus camera you own or add.

Closing a quality gap shouldn’t depend on whether a referral across town actually happens. The most reliable way to close the diabetic eye exam is to never let the patient leave.

How the data and coordination work

A measure only counts if it’s documented in a form your quality and risk teams can use. EyeSee returns a structured, attributable report for every image — findings, severity, and clear language your coders and care managers can map to the gap. That makes the closure auditable for HEDIS abstraction and Stars reporting, not just clinically useful. Because the read happens on your timeline rather than an outside calendar, you can sweep open gaps deliberately at the end of a measurement period instead of hoping referrals resolve in time. See the full services overview for what each report includes.

Where does early detection lower downstream cost?

The retina is the one place a clinician can directly see blood vessels and the optic nerve, so a single photograph can surface diabetic retinopathy, glaucoma, hypertensive changes, and macular disease — often before symptoms appear. In a value-based contract, that early signal matters twice:

• Vision preservation. Catching retinopathy early routes patients to treatment before vision-threatening progression, avoiding the high cost of late-stage intervention.
• Whole-patient signal. Retinal vascular changes can flag poorly controlled disease, helping care teams intervene on the broader condition, not just the eye.

Spending a modest amount on screening today is almost always cheaper than absorbing the downstream cost of advanced disease later — exactly the math value-based care is built to reward.

What does this cost the practice?

Billing is straightforward, but coverage varies by payer and plan, so confirm specifics before you build it into a workflow. In the typical arrangement, the practice captures the image and bills the technical component, while EyeSee provides the professional interpretation. The screening itself is the engine that closes the measure; the read is what makes it clinically and contractually valid. For a plain-language breakdown of who bills for what, see our billing overview, and always apply your own coding and clinical judgment alongside current payer guidance.

Who this fits

Any organization accountable for diabetic-eye performance benefits, but the impact is sharpest where patients are seen often and eye specialists are scarce. Primary care clinics closing the EED measure in-house see the most direct lift, and our who we serve page maps the model to FQHCs, rural health, employer programs, and ACOs working under shared-savings and capitated contracts.

The bottom line

Quality measures reward reliable execution, and referrals are anything but reliable. Bringing the diabetic eye exam to the point of care turns one of your hardest gaps into one of your most dependable closures — while catching sight-threatening disease early enough to matter.

Ready to close the diabetic eye exam without sending patients out the door? Schedule a demo or explore the primary care solution.